MRK vs SOLV
By Alex · Tickerpine
Merck & Company, Inc. vs Solventum Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | SOLV |
|---|---|---|
| Price | $132.92 | $85.29 |
| Market cap | $327.94B | $14.52B |
| P/E ratio | 106.3 | 10.3 |
| ROE | 6.96% | 33.96% |
| Profit margin | 4.77% | 17.26% |
| Revenue growth | 5.10% | 2.20% |
| Dividend yield | 2.56% | — |
| Beta | 0.21 | 0.67 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs SOLV in plain English
- MRK is the bigger company — about 22.6× the market cap of SOLV.
- SOLV is cheaper on earnings (P/E 10.3 vs 106.3).
- SOLV earns a higher return on equity (34% vs 7%).
- MRK is growing revenue faster (5% vs 2%).
- MRK pays a dividend (2.56%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
SOLV return calculator
See what $1,000 in Solventum Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.